A single-dose nanoparticle vaccine protects against mpox in preclinical models
Cell Reports · 2025
DOI: 10.1016/j.celrep.2025.116358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Run-Yu Yuan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, C…. Hauptthemen laut MEDLINE: Nanoparticles, Mpox, Monkeypox, Monkeypox virus, Viral Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The ongoing outbreak and emergence of monkeypox virus (MPXV) clade Ib and IIb lineage have heightened its transmissibility, morbidity, and mortality, underscoring the urgent need for safe and effective vaccines against MPXV infection. In this study, we developed a "two-in-one" nanoparticle vaccine, DAM-NP, which incorporates bivalently fused M1 and A35 antigens conjugated to a self-assembled 24-meric ferritin nanoparticle. Preclinical evaluations demonstrated that DAM-NP elicits robust humoral and cellular immune responses, providing complete protection against lethal vaccinia virus challenge. Importantly, pre-existing antibodies resulting from prior infection with the VACV Tiantan strain utilized for smallpox prevention did not diminish vaccine efficacy. A single dose was sufficient to prevent both morbidity and mortality following a lethal MPXV challenge. These findings establish DAM-NP as a highly immunogenic and promising single-dose vaccine candidate for prevention of MPXV and other orthopoxvirus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China; Guangdong Provincial Institute of Public Health, Guangdong Provi…
- BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research School of Public Health, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China…
- National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control, Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China A…
- Institute of Microbiology, Center for Disease Control and Prevention of Guangdong Province, Guangzhou, China; Guangdong Provincial Key Laboratory of Pathogen Detection for Emerging Infectious Disease Response, Guangzhou…
- Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
- College of Pharmacy, Chongqing Medical University, Chongqing, China.
Zitieren
APA
Yuan, R. Y., Li, M. J., Lin, X. B., Zhang, X., Yu, F., Zhang, X., Qian, Q., Peng, Y., Li, D. L., Zhao, Q. J., Zhang, H., Yang, Y., Shen, C. G., Li, B. S., & Kang, Y. F. (2025). A single-dose nanoparticle vaccine protects against mpox in preclinical models. Cell Reports. https://doi.org/10.1016/j.celrep.2025.116358
Vancouver
Yuan RY, Li MJ, Lin XB, Zhang X, Yu F, Zhang X, et al. A single-dose nanoparticle vaccine protects against mpox in preclinical models. Cell Reports. 2025. doi:10.1016/j.celrep.2025.116358
BibTeX
@article{Yuan2025,
author = {Yuan, Run-Yu and Li, Meng-Jun and Lin, Xiao-Bing and Zhang, Xin and Yu, Fei and Zhang, Xiao and Qian, Qi and Peng, Yun and Li, De-Lin and Zhao, Qin-Jian and Zhang, Hui and Yang, Yang and Shen, Chen-Guang and Li, Bai-Sheng and Kang, Yin-Feng},
title = {A single-dose nanoparticle vaccine protects against mpox in preclinical models},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2025.116358}
}
EUVIMED